Hadasit licenses oral immune modulation technology to Immuron
The combination of Hadasit’s oral immune modulation with Immuron’s existing oral protein and antibody technology could yield a convenient, all-natural, side-effect-free approach to address serious diseases including metabolic
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.